News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Michael Ong received $2.4M for metastatic prostate cancer – CCTG
Photo taken from CCTG/X
Aug 12, 2024, 01:27

Michael Ong received $2.4M for metastatic prostate cancer – CCTG

The Canadian Cancer Trials Group shared on X:

“Congratulations to Dr Michael Ong, who has received $2,487,015 over 7 years from CIHR to support the CCTG PR26 (TRIPLE-SWITCH) trial. The study aims to personalize chemotherapy use and improve survival for patients with metastatic prostate cancer.”

Read further.
Source: The Canadian Cancer Trials Group/X

cancer CCTG chemotherapy metastatic prostate cancer Michael Ong OncoDaily Oncology The Canadian Cancer Trials Group
Special Coverage
Insight
Nov 21, 2024, 13:55
Bridging the Gap Between Innovation and Impact - AIM-HI Accelerator Fund
Blog
Nov 21, 2024, 13:46
NCI signed a MOU with Ministry of Food and Drug of Republic of Korea
Insight
Nov 21, 2024, 13:37
Elizabeth Franklin: Discussing the transformative role of patient navigation in cancer care at the White House
Blog
Nov 21, 2024, 13:25
Core takeaway from LGCW: Inequities are omnipresent and intersectional - Madano
Blog
Nov 21, 2024, 13:03
Ruben Mesa: Kicking off the 4th Dr. Rob Winn Diversity in Clinical Trials Workshop
Insight
Nov 21, 2024, 12:57
Navneet Singh: Molecular testing in all stages of NSCLC
Blog
Nov 21, 2024, 12:54
A Welcome to our new PhD students - Manchester Cancer Research Centre
Blog
Nov 21, 2024, 12:49
Angela Mastronuzzi: New Treatment Perspectives on Infant Tumors
Blog
Nov 21, 2024, 12:41
Fatma Bektash: Pleased to Represent the Breast Cancer Hospital - National Cancer Institute at the MPLEG
Blog
Nov 21, 2024, 12:36
Take Your Career to the Next Level with the IASLC Academy - IASLC
Blog
Nov 21, 2024, 10:02
Staying current on cutting edge research into genetic/familial high-risk assessment - NCCN
Blog
Nov 21, 2024, 09:55
New Hope for Mantle Cell Lymphoma Patients - The Babak Lab